MedTech Terms
    The authoritative reference
    All terms

    Launch Readiness

    Cross-functional checklist confirming a product is ready for commercial release.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Launch readiness is the structured cross-functional gate that confirms a device is ready for commercial release - regulatory clearance, QMS state, supply capacity, sales training, KOL engagement, reimbursement strategy, and post-market surveillance plan.
    What the regulation says
    Regulators do not explicitly define "Launch Readiness" as a distinct regulatory gate; however, they require manufacturers to demonstrate compliance across various regulatory domains prior to placing a device on the market. For instance, the FDA mandates pre-market approval or clearance (21 CFR Part 807, 21 CFR Part 814), and the EU MDR (Regulation (EU) 2017/745) requires conformity assessment and CE marking. Manufacturers must also maintain a robust Quality Management System (QMS), as per 21 CFR Part 820 or ISO 13485:2016, and have a post-market surveillance plan in place, specified in EU MDR Annex III or FDA’s post-market surveillance regulations (21 CFR Part 822).

    What this means in practice

    Missing any one element can stall launch. CMO, CCO, and Quality VP typically co-own the gate.

    Examples

    • Before launching a new Class II cardiovascular device, a manufacturer ensured all 510(k) requirements were met, production lines were validated according to 21 CFR 820.75, and a comprehensive sales training program was completed.
    • A European MedTech company verified that its new in vitro diagnostic (IVD) device had successfully passed its conformity assessment under the EU IVDR, secured manufacturing capacity, and established a detailed post-market performance follow-up plan before commercial release.
    • Following a software update for an existing medical device, the company confirmed that cybersecurity risk assessments were updated per FDA guidance on Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, and the updated software was verified and validated before deployment to market deployment.
    Common pitfalls
    • •Assuming regulatory clearance or approval alone signifies launch readiness without considering other critical elements.
    • •Failing to integrate regulatory and quality milestones into the overall launch readiness checklist.
    • •Underestimating the resources and time required for effective sales force training and post-market surveillance infrastructure.
    • •Neglecting to update launch readiness criteria based on evolving regulatory requirements or market conditions.

    Frequently asked questions

    Launch readiness heavily relies on a mature QMS that ensures all design, manufacturing, and post-market activities comply with regulatory requirements. A QMS provides the documented processes and controls necessary to consistently produce safe and effective devices, which is a prerequisite for market entry.
    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    AdvaMed·2AHRMM·1
    1. 1
      AdvaMed product launch
      Verified
      AdvaMedadvamed.org
    2. 2
      AdvaMed Code of Ethics
      Verified
      AdvaMedadvamed.org
    3. 3
      AHRMM - Healthcare Supply Chain
      Verified
      AHRMMahrmm.org

    Inline markers like [1] jump to the matching reference above.